GENECOPOEIA INC.

Company Overview

GeneCopoeia Inc. is a U.S.-based manufacturer and provider of genomics and proteomics products and services for governmental and academic research institutes and the pharmaceutical and biotechnology industries. The company is headquartered in Maryland. Together with investors in China, GeneCopoeia formed a joint venture, FulenGen Co. Ltd., in China.

The firm’s mission is to become a premier provider of technologies, products, services, and tools for research discoveries and product development in the fields of biological and biomedical research. Emphasis is placed on the manufacture and distribution of genomics and proteomics-based biological research reagent products, including nucleic acid-, protein-, and antibody-based research reagent products and services.

GeneCopoeia and FulenGen have manufactured and launched many human full-length protein-coding open reading frame copy DNA (cDNA) clones in multiple sets of vector systems for various functional assays, protein expression, and easy purification in many cell types as well as cell-free transcription and translation coupling systems, and large-scale functional genomics and proteomics studies. GeneCopoeia offers lentivirus particles, cDNA clones, and short hairpin RNA (shRNA) clones for iPSC research.

Company's Business Segments

• Products and Services : The company generates revenue through several product and service lines, such as Clone Collections, Genome Editing Tools, Viral Delivery Systems, Stable Cell Lines, miRNA Solutions, Antibody Microarrays, Exosome Solutions, Custom Services, COVID-19 coronavirus research tools, qPCR Products, Luciferase assays and reporters, Reagent Kits and Proteins.